Key result
In patients older than 80 years with acute ischemic stroke, alteplase treatment significantly improved the adjusted odds of achieving functional independence at discharge (aOR 1.12).
Why the study?
Outcomes and risks of IV thrombolysis in patients over 80 years with acute ischemic stroke treated within 3 hours versus 3 to 4.5 hours were not well defined.
Cohort (n=30,902)
Yes
Answers are grounded in this paper and cite their sources.
Supports the potential benefit of thrombolysis in octogenarians; extends prior trial data into real-.
OBJECTIVE: To determine outcomes and risks of IV thrombolysis (IVT) in patients with acute ischemic stroke (AIS) >80 years of age within 3 hours compared to >3 to 4.5 hours recorded in the Safe Implementation of Treatment in Stroke (SITS) International Stroke Thrombolysis Registry. METHODS: A total of 14,240 (year 2003-2015) patients >80 years of age with AIS were treated with IVT ≤4.5 hours of stroke onset (3,558 in >3-4.5 hours). Of these, 8,658 (2,157 in >3-4.5 hours) were treated otherwise according to the European Summary of Product Characteristics (EU SmPC) criteria for alteplase. Outcomes were 3-month functional independence (modified Rankin Scale score 0-2), mortality, and symptomatic intracerebral hemorrhage (SICH)/SITS. Results were compared between the groups treated in >3 to 4.5 and ≤3 hours. CONCLUSIONS: In this observational study, unselected patients >80 years of age treated with IVT after 3 hours vs earlier had a slightly higher rate of SICH and similar unadjusted functional outcome but poorer adjusted outcome. The absolute difference between the treatment groups is small, and elderly patients should not be denied IVT in the later time window solely because of age without other contraindications.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2017) conducted a cohort in Acute ischemic stroke (n=30,902). Alteplase (intravenous thrombolysis) vs. Without alteplase was evaluated on Modified Rankin Scale (mRS) score of 0-2 at discharge (aOR 1.12, 95% CI 1.06-1.18, p=<0.001). In patients older than 80 years with acute ischemic stroke, alteplase treatment significantly improved the adjusted odds of achieving functional independence at discharge (aOR 1.12).
Synapse has enriched 10 related papers. Consider them for comparative context: